Search research articles
Contact Us
Filters
Showing results (71-80 of 114) with videos related to
Page
of 12
Sort By:
EMBO Molecular Medicine
|
May 1, 2010
Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine
Dora Dias-Santagata, Sara Akhavanfard, Serena S David, et al.
Cancer Cell
|
July 13, 2013
A genetic progression model of Braf(V600E)-induced intestinal tumorigenesis reveals targets for therapeutic intervention
Roland Rad, Juan Cadiñanos, Lena Rad, et al.
Molecular Cancer Therapeutics
|
December 29, 2012
VS-5584, a novel and highly selective PI3K/mTOR kinase inhibitor for the treatment of cancer
Stefan Hart, Veronica Novotny-Diermayr, Kee Chuan Goh, et al.
Gut
|
July 22, 2020
Image-based consensus molecular subtype (imCMS) classification of colorectal cancer using deep learning
Korsuk Sirinukunwattana, Enric Domingo, Susan D Richman, et al.
Cell Reports
|
August 31, 2017
Genomic Determinants of Protein Abundance Variation in Colorectal Cancer Cells
Theodoros I Roumeliotis, Steven P Williams, Emanuel Gonçalves, et al.
Cell Cycle (Georgetown, Tex.)
|
November 22, 2017
Single agent and synergistic combinatorial efficacy of first-in-class small molecule imipridone ONC201 in hematological malignancies
Varun V Prabhu, Mala K Talekar, Amriti R Lulla, et al.
The Journal of Pathology
|
December 23, 2024
Tumour purity assessment with deep learning in colorectal cancer and impact on molecular analysis
Lydia A Schoenpflug, Aikaterini Chatzipli, Korsuk Sirinukunwattana, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 20, 2019
Molecular Evolution of <i>IDH</i> Wild-Type Glioblastomas Treated With Standard of Care Affects Survival and Design of Precision Medicine Trials: A Report From the EORTC 1542 Study
Kaspar Draaisma, Aikaterini Chatzipli, Martin Taphoorn, et al.
Cell Reports
|
June 21, 2016
BRAF(V600E) Kinase Domain Duplication Identified in Therapy-Refractory Melanoma Patient-Derived Xenografts
Kristel Kemper, Oscar Krijgsman, Xiangjun Kong, et al.
Cell Reports
|
October 21, 2016
A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia
Konstantinos Tzelepis, Hiroko Koike-Yusa, Etienne De Braekeleer, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 114) with videos related to
Sort By:
Page
of 12
EMBO Molecular Medicine
|
May 1, 2010
Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine
Dora Dias-Santagata, Sara Akhavanfard, Serena S David, et al.
Cancer Cell
|
July 13, 2013
A genetic progression model of Braf(V600E)-induced intestinal tumorigenesis reveals targets for therapeutic intervention
Roland Rad, Juan Cadiñanos, Lena Rad, et al.
Molecular Cancer Therapeutics
|
December 29, 2012
VS-5584, a novel and highly selective PI3K/mTOR kinase inhibitor for the treatment of cancer
Stefan Hart, Veronica Novotny-Diermayr, Kee Chuan Goh, et al.
Gut
|
July 22, 2020
Image-based consensus molecular subtype (imCMS) classification of colorectal cancer using deep learning
Korsuk Sirinukunwattana, Enric Domingo, Susan D Richman, et al.
Cell Reports
|
August 31, 2017
Genomic Determinants of Protein Abundance Variation in Colorectal Cancer Cells
Theodoros I Roumeliotis, Steven P Williams, Emanuel Gonçalves, et al.
Cell Cycle (Georgetown, Tex.)
|
November 22, 2017
Single agent and synergistic combinatorial efficacy of first-in-class small molecule imipridone ONC201 in hematological malignancies
Varun V Prabhu, Mala K Talekar, Amriti R Lulla, et al.
The Journal of Pathology
|
December 23, 2024
Tumour purity assessment with deep learning in colorectal cancer and impact on molecular analysis
Lydia A Schoenpflug, Aikaterini Chatzipli, Korsuk Sirinukunwattana, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 20, 2019
Molecular Evolution of <i>IDH</i> Wild-Type Glioblastomas Treated With Standard of Care Affects Survival and Design of Precision Medicine Trials: A Report From the EORTC 1542 Study
Kaspar Draaisma, Aikaterini Chatzipli, Martin Taphoorn, et al.
Cell Reports
|
June 21, 2016
BRAF(V600E) Kinase Domain Duplication Identified in Therapy-Refractory Melanoma Patient-Derived Xenografts
Kristel Kemper, Oscar Krijgsman, Xiangjun Kong, et al.
Cell Reports
|
October 21, 2016
A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia
Konstantinos Tzelepis, Hiroko Koike-Yusa, Etienne De Braekeleer, et al.
Page
of 12